Diabetic Products

Home » shop » Diabetic Products
  • sinjard
    Product Description: Sinjard is a preparation of empagliflozin. Empagliflozin is an inhibitor of Sodium-glucose co-transporter 2 (SGLT2). SGLT2 is the predominant transporter responsible for reabsorption of glucose from the kidney back into the circulation. By inhibiting SGLT2, Empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion. Empagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and- to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease. Product Features:
    Product Name : Sinjard
    Generic Name : Empagliflozin INN
    Formulation :  Tablet
    Available Pack Size : 10 mg & 25 mg (Tablet)
    Available Strength : Sinjard 10 Tablet (7 x 4’s), Sinjard 25 Tablet (7 x 2’s)
    Registrations : Bangladesh
       
  • Product Description: Glipxen is a preparation of linagliptin which is indicated to improve glycemic control in patients with type 2 diabetes mellitus. Linagliptin is an inhibitor of DPP-4 (dipeptidyl peptidase-4), an enzyme that degrades the incretin hormones GLP-1 (glucagon like peptide-1) and GIP (glucose dependent insulinotropic polypeptide). Thus, Linagliptin increases the concentrations of active incretin hormones, stimulating the release of insulin from pancreatic beta (1) cells in a glucose-dependent manner and decreasing the secretion of glucagon from pancreatic alpha (α) cells in the circulation. Product Features:
    Product Name : Glipxen
    Generic Name : linagliptin INN
    Formulation :  Tablet
    Available Pack Size : 5 mg (Tablet)
    Available Strength : Glipxen 5 Tablet (7 x 4’s)
    Registrations : Bangladesh
       
  • Product Description: Xelmet is a biguanide type oral antihyperglycemic drug used in the management of type 2 diabetes. It lowers both basal and postprandial plasma glucose. Its mechanism of action is different from those of sulfonylureas and it does not produce hypoglycemia. Xelmet decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by an increase in peripheral glucose uptake and utilization. Product Features:
    Product Name : Xelmet
    Generic Name : Metformin Hydrochloride BP
    Formulation :  Tablet
    Available Pack Size : 60’s (Tablet)
    Available Strength : 500 mg
    Registrations : Bangladesh